Condition
Vaccine Exposure During Pregnancy
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
1Total
P 4 (1)
Trial Status
Recruiting2
Terminated1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06135636Phase 4Recruiting
Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy
NCT06097312RecruitingPrimary
PREHEVBRIO Pregnancy Outcomes Registry
NCT01374009TerminatedPrimary
H1N1 Vaccine in Pregnancy: a Registry for the Fall and Winter of 2009
Showing all 3 trials